Cambridge Epigenetix
The new assay allows researchers to sequence the four canonical DNA bases as well as 5-methylcytosine and 5-hydroxymethylcytosine from the same molecule.
People in the News at Adaptive Biotechnologies, Biocartis, Sherlock Biosciences, Epigenomics, More
Executive and academic appointments, promotions, and departures in omics and molecular diagnostics for the week of April 10, 2023.
Cambridge Epigenetix Rebrands as Biomodal; Launches Combined Genetic, Epigenetic Sequencing Tech
Premium
The UK company has released a kit for joint genetic and epigenetic profiling based on the five-letter sequencing technology developed by Shankar Balasubramanian’s lab.
Cambridge Epigenetix Raises $88M in Series D Funding Round
The firm will use the proceeds to commercialize its genomic and epigenomic sequencing technology, which it expects to sell early next year.